Rodman & Renshaw has issued a mid-day downgrade on shares of the momentous Arena Pharma (Nasdaq: ARNA). The firm moved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE